Different clinical and neurobiologic pathways may be involved in treatment-resistant schizophrenia as it is not a homogeneous subgroup within the schizophrenia spectrum.
All articles by Douglas Strassler
For patients with bipolar disorder and major depressive disorder, reduction in dose of antipsychotic medication could lead to an increased rate of hospitalization.
Augmentation therapy for treatment-resistant major depressive disorder includes multiple options with different strengths and limitations.
Children who are diagnosed on the autism spectrum are protected by their parents and community and are not properly actualized.
Updates made to the DSM-5 will clarify the diagnosis of bipolar disorder and related disorders.
Obsessive-compulsive disorder is a common disabling psychiatric condition.
Michael Thase, MD, discusses therapy options as well as side effect management for individuals with major depressive disorder.
The Psych Congress’s mission is to connect professionals representing all aspects of mental health treatment.
Scores for both anxiety and depression are associated with low BMD.
In children with autism, improvisational music therapy showed no significant difference in symptom outcome.
New data were presented at the IAS Conference, pertaining to predictive factors and cognitive screening for HIV-associated neurocognitive disorders.
New bipolar I disorder treatment Abilify Maintena is only required once a month.
Clozapine might lower risk of self-harm for patients with treatment-resistant schizophrenia.
Autism risk is correlated with exposure to certain toxins and nutrients during late pregnancy.
Depression’s effect at 2 points before breast cancer diagnosis was studied for the first time.
Interventions targeted at improving medication adherence might mitigate adverse effects of cannabis use on psychosis outcomes.
The positive effects of antipsychotic medications in patients with schizophrenia and other psychotic disorders outweigh the adverse effects of antipsychotics on long-term outcomes.
Antidepressant treatment in combination with DMARDs and biologics led to the best positive dynamics of mental disorder frequency.
Depressive symptoms in patients with rheumatoid arthritis can be reduced by using sirukumab.
Quality of sleep was associated with various aspects of life, especially pain, vitality, and emotional health.
Cognitive dysfunction is 3 times higher in patients with systemic lupus erythematosus.
Mental health and behavioral screenings should be routine part of care for pediatric patients with diabetes.
In patients with schizophrenia being treated with clozapine or olanzapine, liraglutide significantly improved glucose tolerance, body weight, and other cardiometabolic disturbances.
Binge eating disorder is the most common eating disorder in adults and has the potential for serious health implications if left untreated.
A new ADHD treatment option could improve early morning functioning in children.
Lurasidone is an atypical antipsychotic that has demonstrated efficacy in the treatment of schizophrenia in adolescents.
Psychiatric manifestations of Huntington disease include cognitive decline, depressive and manic symptoms, and psychosis.
Both pain response and development of chronic pain are significantly linked to trauma exposure.
Serum IL-6 levels may serve as biomarkers for Alzheimer’s disease.
Bipolar depression treatment response to lurasidone between baseline and week 2 indicates later treatment success.
Latest News Your top articles for Friday
Haymarket Medical NetworkTop Picks